[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google

First-Time Generics - November 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 IBUPROFEN/PSEUDOEPHEDRINE HYDROCHLORIDE ORAL SUSPENSION 100 MG/15 MG PER 5 ML, BERRY, GRAPE, AND BUBBLE GUM FLAVORS PERRIGO COMPANY CHILDREN'S MOTRIN COLD ORAL SUSPENSION 11/5/2003
2 FLUOROURACIL TOPICAL SOLUTION, USP 2% AND 5% TARO PHARMACEUTICAL INDUSTRIES LTD. EFUDEX TOPICAL SOLUTION 11/5/2003
3 LORATADINE SYRUP 5 MG/5 ML TEVA PHARMACEUTICALS USA CLARITIN SYRUP 11/7/2003
4 GLIPIZIDE EXTENDED-RELEASE TABLETS 10 MG WATSON LABORATORIES, INC. GLUCOTROL XL EXTENDED-RELEASE TABLETS 11/7/2003
5 MUPIROCIN OINTMENT, USP 2% TEVA PHARMACEUTICALS USA BACTROBAN OINTMENT 11/7/2003
6 METRONIDAZOLE CAPSULES 375 MG ABLE LABORATORIES, INC. FLAGYL 375 CAPSULES 11/13/2003
7 FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75mcg/hr, AND 100 mcg/hr MYLAN TECHNOLOGIES, INC. DURAGESIC TRANSDERMAL SYSTEM 11/21/2003
8 FOSINOPRIL SODIUM TABLETS 10 MG, 20 MG, AND 40 MG TEVA PHARMACEUTICALS USA MONOPRIL TABLETS 11/25/2003
9 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS 100 MG EON LABS, INC. WELLBUTRIN SR TABLETS, 100 MG 11/25/2003

Back to Top     Back to Approvals

Date created: 12/8/2003

horizonal rule